Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novel technique enables tiny bone prosthetics to be made from titanium:

This article was originally published in Clinica

Executive Summary

Tiny prosthetic bones replicating structures such as the stirrup - a small bone in the ear - can now be made from titanium using a novel injection-moulding technique. The technique - called micro metal powder injection-moulding (micro-MIM) - uses a fine metal powder that enables the replication of very small structures, said the developers of the technology, based at the Fraunhofer Institute for Manufacturing Technology and Applied Materials Research (IFAM) in Bremen, Germany. It has been possible for some time to make small metal parts from stainless steel. Until now the production of tiny metal parts has used techniques such as etching or milling which is a very complex and time-consuming process, and not suitable for many types of metal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048465

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel